DK2209527T3 - Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom - Google Patents

Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom

Info

Publication number
DK2209527T3
DK2209527T3 DK08838386.4T DK08838386T DK2209527T3 DK 2209527 T3 DK2209527 T3 DK 2209527T3 DK 08838386 T DK08838386 T DK 08838386T DK 2209527 T3 DK2209527 T3 DK 2209527T3
Authority
DK
Denmark
Prior art keywords
acidophilus
treatment
pharmaceutical compositions
bowel disease
bifidobacterium lactis
Prior art date
Application number
DK08838386.4T
Other languages
English (en)
Inventor
Arthur Ouwehand
Gregory Leyer
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40549819&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2209527(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK2209527T3 publication Critical patent/DK2209527T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK08838386.4T 2007-10-11 2008-10-08 Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom DK2209527T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97918707P 2007-10-11 2007-10-11
PCT/US2008/079177 WO2009048934A2 (en) 2007-10-11 2008-10-08 Probiotics for use in relieving symptoms associated with gastrointestinal disorders

Publications (1)

Publication Number Publication Date
DK2209527T3 true DK2209527T3 (da) 2013-03-18

Family

ID=40549819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08838386.4T DK2209527T3 (da) 2007-10-11 2008-10-08 Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom

Country Status (11)

Country Link
US (1) US9055763B2 (da)
EP (1) EP2209527B1 (da)
JP (2) JP5758629B2 (da)
CN (1) CN101998834B (da)
AU (2) AU2008310961B2 (da)
CA (1) CA2702293C (da)
DK (1) DK2209527T3 (da)
ES (1) ES2399775T3 (da)
HK (1) HK1146914A1 (da)
PL (1) PL2209527T3 (da)
WO (1) WO2009048934A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
WO2015129281A1 (ja) * 2014-02-28 2015-09-03 株式会社明治 機能性消化管障害予防及び／又は改善剤
EP3524051A1 (en) 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions
US20210401905A1 (en) * 2018-03-05 2021-12-30 Kerry Luxembourg S.à.r.l Combination of lactobacilli for the relief of irritable bowel syndrome and for the relief of other gastrointestinal disorders
EP3821718A1 (en) * 2019-11-15 2021-05-19 DuPont Nutrition Biosciences ApS Probiotics for lactose intolerance
US11742069B2 (en) * 2021-02-01 2023-08-29 Kpn Innovations, Llc. Systems and methods for generating a nociception nourishment program
WO2023154787A1 (en) * 2022-02-09 2023-08-17 The Regents Of The University Of Michigan Compositions and methods for modulating gut microbiomes
CN116746683A (zh) * 2023-08-01 2023-09-15 河北源民生物科技有限公司 防消化不良胀气、促吸收的动物双歧杆菌乳亚种bal-28及发酵产物、菌群cw和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4196132B2 (ja) * 1997-12-22 2008-12-17 小林製薬株式会社 脱ガス組成物
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20070148147A1 (en) * 2002-12-05 2007-06-28 Veronique Dennin Bacterial composition and its use
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2006097949A1 (en) 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
WO2007085970A2 (en) * 2006-01-27 2007-08-02 Danisco A/S Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders

Also Published As

Publication number Publication date
JP5758629B2 (ja) 2015-08-05
AU2008310961A1 (en) 2009-04-16
JP5674741B2 (ja) 2015-02-25
WO2009048934A3 (en) 2009-10-29
AU2008310961B2 (en) 2014-08-28
CN101998834B (zh) 2017-05-10
ES2399775T3 (es) 2013-04-03
HK1146914A1 (en) 2011-07-22
JP2013040186A (ja) 2013-02-28
CA2702293A1 (en) 2009-04-16
JP2011501664A (ja) 2011-01-13
PL2209527T3 (pl) 2013-03-29
WO2009048934A2 (en) 2009-04-16
EP2209527B1 (en) 2012-12-05
US9055763B2 (en) 2015-06-16
AU2014210581A1 (en) 2014-08-28
CA2702293C (en) 2016-08-02
AU2014210581B2 (en) 2016-07-14
US20110033423A1 (en) 2011-02-10
CN101998834A (zh) 2011-03-30
EP2209527A2 (en) 2010-07-28

Similar Documents

Publication Publication Date Title
DK2209527T3 (da) Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom
HK1203960A1 (en) Human protein tyrosine phosphatase inhibitors and their pharmaceutical use
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
IL222880A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
PT2601961T (pt) Composições compreendendo lag-3 e anticorpos terapêuticos e as suas utilizações no tratamento de cancro
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
IL184735A0 (en) Pharmaceutical formulations and methods of use
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
WO2008106102A9 (en) Inhibitors of rtp801 and their use in disease treatment
EP2064550A4 (en) PRRG4 ASSOCIATED COMPOSITIONS AND METHOD FOR USE THEREOF FOR TUMOR DIAGNOSTIC PROCEDURES
IL200549A0 (en) 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
IL204741A (en) Ceramide History for the Treatment of Multiple Cyst Diseases and Pharmaceuticals Containing These History
EP2170404A4 (en) COMPOSITIONS WITH HUMAN EGFR SIRNA AND METHOD OF USE
IL206690A0 (en) Protein kinase inhibitors and their use in the preparation of medicaments
EP1930001A4 (en) PHARMACEUTICAL AGENT FOR THE PREVENTION AND / OR TREATMENT OF THOROTIC DISEASES
HK1147991A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
IL211904A (en) Kit and preparations containing methotrexate and anti-cd4 antibody for the treatment of rheumatic disease
IL195155A (en) Dosage form for delayed glucocorticoid release and its use in the treatment of rheumatic diseases
EP2231148A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE
GB0614365D0 (en) Pharmaceutical compositions and their use
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss